Speaker illustration

Professor Svetlana Apostolovic

Clinical Center of Nis, Nis (Serbia)

Member of:

European Society of Cardiology

Svetlana Apostolović is full profesor of cardiology, in Cardiology Clinic, UCC Nis, Serbia. She is Interventional cardiologist from 2000 y , Echocardiographer: transthoracic and transesophageal from 1995 y, Clinical researcher, Emergency cardiologist. From 2005 y, she is a coordinator of scientific training in Cardiology Clinic, Nis, Head of Coronary Care Unit from 2020 y. She was a PI at 28 Clinical trials. From 2022 y. she organized a SCAD Registered as Serbian National Coordinator and participator of ESC SCAD Registry. Editor of issue dedicated to SCAD with 9 papers in Frointiers in Cardiovascular Medicine. Member of the board of the Association of Cardiologist of Serbia.

Prevention of erectile dysfunction - sign of a good prognosis after acute myocardial infarction

Event: EuroPrevent 2017

Topic: Epidemiology, lipids

Session: Epidemiology/ Public health_Part 1

Thumbnail

Influence of optimized beta-blocker therapy on diastolic dysfunction determined echocardiographically in heart failure patients

Event: EuroEcho-Imaging 2016

Topic: Assessment of diastolic function

Session: Assessment of morphology and function

Thumbnail

Depression in chronic heart failure patients: to use beta-blockers and to cooperate with psychiatrists

Event: ESC Congress 2016

Topic: Heart failure, other

Session: Heart failure

Thumbnail

Mid-regional pro-adrenomedullin as a prognostic indicator of 1-year mortality after acute heart failure. MOLITOR substudy.

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

CT-pro-endothelin-1 in heart failure patients with reduced and preserved ejection fraction - useful or waste of resources? MOLITOR substudy.

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

Clinical significance of growth differentiation factor-15 in patients with acute decompensated heart failure

Event: HEART FAILURE 2016

Topic: Prognosis (using biomarkers)

Session: Biomarkers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb